☆ 4.3 Article

Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Clinical Neurology

Plasma NfL is associated with the APOE ε4 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults

Michael Malek-Ahmadi et al.

Summary: This study found that plasma neurofilament light (NfL) concentrations are higher in cognitively unimpaired older adults with the APOE epsilon 4 allele, which is the major genetic risk factor for Alzheimer's disease (AD). Plasma NfL concentrations were also significantly associated with AD-related neurodegeneration, amyloid-beta plaque burden, tau tangle burden, and memory scores.

ALZHEIMERS RESEARCH & THERAPY (2023)

添加到收藏夹

Article Psychology, Clinical

Time to diagnosis in younger-onset dementia and the impact of a specialist diagnostic service

Samantha M. Loi et al.

Summary: This study identified predictors of delay to diagnosis in people with younger-onset dementia (YOD) and found that younger age at onset, dementia type other than Alzheimer's disease (AD) and behavioral-variant frontotemporal dementia (bvFTD), and increased number of services consulted were significant predictors of diagnostic delay. Additionally, the study showed that a specialist YOD service can reduce time to diagnosis, highlighting the importance of such service in reducing diagnostic delay and providing post-diagnostic support.

INTERNATIONAL PSYCHOGERIATRICS (2022)

添加到收藏夹

Article Clinical Neurology

Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings

Dhamidhu Eratne et al.

Summary: This study investigated the clinical value of cerebrospinal fluid (CSF) neurofilament light (NfL) and total-tau (t-tau) in differentiating neurodegenerative disorders (ND) from psychiatric disorders (PSY) and rapidly progressive disorders. The results showed that NfL had a high accuracy in distinguishing ND from PSY, outperforming t-tau in most clinical scenarios. However, it was not effective in distinguishing Creutzfeldt-Jakob disease (CJD) from rapidly progressive dementias/atypically rapid variants of common ND (RapidND).

ALZHEIMERS & DEMENTIA (2022)

添加到收藏夹

Article Psychiatry

Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives

Dhamidhu Eratne et al.

Summary: This study investigated the levels of plasma neurofilament light chain protein (NfL) in individuals with treatment-resistant schizophrenia, finding no association with neuronal degeneration. Further research is needed to explore the potential utility of NfL in distinguishing treatment-resistant schizophrenia from neurodegenerative disorders, and to examine its role in other stages of schizophrenia.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2022)

添加到收藏夹

Article Clinical Neurology

Neurofilament Light Chain Levels in Anti-NMDAR Encephalitis and Primary Psychiatric Psychosis

Mar Guasp et al.

Summary: This study evaluated the performance of neurofilament light chain (NfL) testing in diagnosing anti-NMDA receptor encephalitis (NMDARe) and first episode of psychosis (FEP) caused by a psychiatric disease. The results showed that NfL levels were associated with disease severity in NMDARe but not with long-term outcome. FEP patients with NfL levels ≥15 pg/mL had a significantly higher chance of having NMDARe.

NEUROLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease

Pratishtha Chatterjee et al.

Summary: This study found that GFAP and p-tau have good diagnostic and longitudinal monitoring potential in preclinical Alzheimer's disease. Combining GFAP with other proteins can improve diagnostic accuracy.

ALZHEIMERS & DEMENTIA (2022)

添加到收藏夹

Article Clinical Neurology

The Diagnostic Challenge of Young-Onset Dementia Syndromes and Primary Psychiatric Diseases: Results From a Retrospective 20-Year Cross-Sectional Study

Paraskevi Tsoukra et al.

Summary: The stability of initial diagnoses in younger patients with neurocognitive disorders is low, especially in cases of behavioral variant frontotemporal dementia. Factors such as cognitive score, follow-up duration, delay to final diagnosis, and family history of dementia may influence diagnostic changes.

JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2022)

添加到收藏夹

Article Clinical Neurology

Neurofilaments light: Possible biomarker of brain modifications in bipolar disorder

Veronica Aggio et al.

Summary: This study investigated the association between neurofilament light (NfL) levels and white matter microstructure in bipolar disorder (BD) patients. The results showed that NfL levels were higher in BD patients compared to healthy controls. Furthermore, a positive correlation was found between NfL levels and axial diffusivity (AD). These findings suggest the presence of neurodegeneration and regeneration processes in BD.

JOURNAL OF AFFECTIVE DISORDERS (2022)

添加到收藏夹

Article Clinical Neurology

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study

Pascal Benkert et al.

Summary: sNfL is a biomarker of neuronal damage used in monitoring disease activity in multiple sclerosis patients. This study established a reference database to correct for age and BMI, showing sNfL's potential in identifying individuals at risk for future disease activity. The results suggest that sNfL Z scores could predict acute and chronic disease activity in multiple sclerosis patients, with higher Z scores indicating increased risk.

LANCET NEUROLOGY (2022)

添加到收藏夹

Article Neurosciences

Renal Function and Body Mass Index Contribute to Serum Neurofilament Light Chain Levels in Elderly Patients With Atrial Fibrillation

Alexandros A. Polymeris et al.

Summary: This study investigated the association between renal function, BMI, and sNfL in elderly patients with atrial fibrillation. The results showed that both renal function and BMI were associated with sNfL, but renal function explained a larger proportion of sNfL variance.

FRONTIERS IN NEUROSCIENCE (2022)

添加到收藏夹

Article Clinical Neurology

Contributors to Serum NfL Levels in People without Neurologic Disease

Kathryn C. Fitzgerald et al.

Summary: This study aimed to assess the effects of demographics, lifestyle factors, and comorbidities on serum neurofilament light chain (sNfL) levels in individuals without neurologic disease and establish population-specific reference ranges for sNfL. The study analyzed data from the National Health and Nutrition Examination Survey (NHANES) and found that age, creatinine, and glycosylated hemoglobin (HbA1c) were the best predictors of sNfL levels. The results provide guidance for interpreting sNfL levels in relation to neurologic conditions.

ANNALS OF NEUROLOGY (2022)

添加到收藏夹

Article Neurosciences

Plasma Neurofilament Light Chain and Clinical Diagnosis in Frontotemporal Dementia Syndromes

Suyi Ooi et al.

Summary: The study found that plasma neurofilament light chain (NfL) levels can help distinguish between frontotemporal dementia (FTD) syndromes and mimics, but may not fully differentiate slow progressors; NfL levels are higher in FTD patients. More patient data is needed to strengthen diagnostic utility.

JOURNAL OF ALZHEIMERS DISEASE (2022)

添加到收藏夹

Article Clinical Neurology

Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressors

Dhamidhu Eratne et al.

Summary: This study demonstrates the strong diagnostic utility of cerebrospinal fluid neurofilament light chain (NfL) in distinguishing behavioral variant frontotemporal dementia (bvFTD) from non-progressor variants, with high accuracy at baseline. This has important implications for clinicians and patients, improving outcomes in challenging clinical dilemmas, healthcare services, and clinical trials.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2022)

添加到收藏夹

Article Clinical Neurology

Age- and disease-specific reference values for neurofilament light presented in an online interactive support interface

Lisa Vermunt et al.

Summary: Interpretation of axonal damage biomarker NfL concentrations is challenging due to the lack of age-specific and disease-specific reference values. We developed an interactive interface to provide reference values and support clinicians in interpreting individual patient results in human body fluids.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2022)

添加到收藏夹

Article Clinical Neurology

Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5-90 years

Joel Simren et al.

Summary: The recent development of a new method to accurately measure neurofilament light in plasma has revealed its potential as a sensitive and robust biomarker for neuroaxonal damage. Efforts are now being made to incorporate plasma neurofilament light into clinical practice and establish reference values to aid interpretation of test results.

BRAIN COMMUNICATIONS (2022)

添加到收藏夹

Article Psychiatry

Altered neuroaxonal integrity in schizophrenia and major depressive disorder assessed with neurofilament light chain in serum

Francesco Bavato et al.

Summary: The study found that NfL levels were significantly higher in the MDD group compared to the healthy norm population, while no significant increase was observed in the SZ group, and there was no correlation between NfL and inflammatory markers. In the DSST test, a negative correlation was observed between NfL values and cognitive performance in patients with MDD.

JOURNAL OF PSYCHIATRIC RESEARCH (2021)

添加到收藏夹

Article Multidisciplinary Sciences

A multicentre validation study of the diagnostic value of plasma neurofilament light

Nicholas J. Ashton et al.

Nature Communications (2021)

添加到收藏夹

Review Neurosciences

Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain

Lorenzo Gaetani et al.

Summary: Identifying neurological diseases in their presymptomatic phase is crucial for future research. NfL, a biomarker, has shown promising results in detecting diseases early and understanding the pathophysiology.

FRONTIERS IN NEUROSCIENCE (2021)

添加到收藏夹

Article Psychiatry

A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?

Dhamidhu Eratne et al.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2020)

添加到收藏夹

Article Clinical Neurology

Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders

Kasper Katisko et al.

JOURNAL OF NEUROLOGY (2020)

添加到收藏夹

Review Clinical Neurology

Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders

Simon Ducharme et al.

BRAIN (2020)

添加到收藏夹

Article Clinical Neurology

A combination of total tau and neurofilaments discriminates between neurodegenerative and primary psychiatric disorders

A. Fourier et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

添加到收藏夹

Article Clinical Neurology

Confounding effect of blood volume and body mass index on blood neurofilament light chain levels

Ali Manouchehrinia et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Plasma β-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia

Daniela Rodrigues-Amorim et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Renal function is associated with blood neurofilament light chain level in older adults

Shoshin Akamine et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Medicine, General & Internal

A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo

Michael Berk et al.

BMC MEDICINE (2019)

添加到收藏夹

Article Psychiatry

Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia

M. H. D. Rami Al Shweiki et al.

JOURNAL OF PSYCHIATRIC RESEARCH (2019)

添加到收藏夹

Review Clinical Neurology

Neurofilament light chain as a biomarker in neurological disorders

Lorenzo Gaetani et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

添加到收藏夹

Review Clinical Neurology

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

Claire Bridel et al.

JAMA NEUROLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Elevated ubiquitinated proteins in brain and blood of individuals with schizophrenia

Chad A. Bousman et al.

SCIENTIFIC REPORTS (2019)

添加到收藏夹

Review Clinical Neurology

Neurofilaments as biomarkers in neurological disorders

Michael Khalil et al.

NATURE REVIEWS NEUROLOGY (2018)

添加到收藏夹

Article Psychiatry

Elevated peripheral expression of neuregulin-1 (NRG1) mRNA isoforms in clozapine-treated schizophrenia patients

Md Shaki Mostaid et al.

TRANSLATIONAL PSYCHIATRY (2017)

添加到收藏夹

Article Psychiatry

Adjunctive minocycline treatment for major depressive disorder: A proof of concept trial

Olivia M. Dean et al.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Cognitive Performance and Cerebrospinal Fluid Biomarkers of Neurodegeneration: A Study of Patients with Bipolar Disorder and Healthy Controls

Sindre Rolstad et al.

PLOS ONE (2015)

添加到收藏夹

Article Neurosciences

Elevated Concentrations of Neurofilament Light Chain in the Cerebrospinal Fluid of Bipolar Disorder Patients

Joel Jakobsson et al.

NEUROPSYCHOPHARMACOLOGY (2014)

添加到收藏夹

Review Neurosciences

Protocol and Rationale-The Efficacy of Minocycline as an Adjunctive Treatment for Major Depressive Disorder: A Double Blind, Randomised, Placebo Controlled Trial

Olivia May Dean et al.

CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2014)

添加到收藏夹

Article Psychology, Clinical

The Diagnostic Challenge of Psychiatric Symptoms in Neurodegenerative Disease: Rates of and Risk Factors for Prior Psychiatric Diagnosis in Patients With Early Neurodegenerative Disease

Josh D. Woolley et al.

JOURNAL OF CLINICAL PSYCHIATRY (2011)

添加到收藏夹

Article Clinical Neurology

Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD

M Sjögren et al.

NEUROLOGY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.